terfenadine Seldane withdrawn
Selected indexed studies
- Cardiovascular safety of antihistamines. (Postepy Dermatol Alergol, 2014) [PMID:25097491]
- Seldane approval may be withdrawn by FDA. (AIDS Patient Care STDS, 1997) [PMID:11361802]
- Drug-induced cholestasis. (Semin Gastrointest Dis, 2001) [PMID:11352118]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma. (1998) pubmed
- Pharmacokinetic profile of zafirlukast. (2002) pubmed
- Cardiovascular safety of antihistamines. (2014) pubmed
- Pharmacokinetic overview of oral second-generation H1 antihistamines. (1998) pubmed
- ML368 Identification of Imidazopyridines as Selective Inhibitors of the Cytochrome P450 Enzyme CYP3A4. (2010) pubmed
- Seldane approval may be withdrawn by FDA. (1997) pubmed
- Drug-induced cholestasis. (2001) pubmed
- Terfenadine should be withdrawn from clinical use. (1999) pubmed
- Application of data mining techniques in pharmacovigilance. (2004) pubmed
- [Drug interactions. Mechanisms and clinical relevance]. (2003) pubmed